Authors: Ferrero-Pous, M Hersant, AM Pecking, A Bresard-Leroy, M Pichon, MF

Citation: M. Ferrero-pous et al., Serum chromogranin-A in advanced prostate cancer, BJU INT, 88(7), 2001, pp. 790-796

Authors: Ferrero-Pous, M Trassard, M Le Doussal, V Hacene, K Tubiana-Hulin, M Spyratos, F

Citation: M. Ferrero-pous et al., Comparison of enzyme immunoassay and immunohistochemical measurements of estrogen and progesterone receptors in breast cancer patients, APPL IMMUNO, 9(3), 2001, pp. 267-275

Authors: Spyratos, F Ferrero-Pous, M Tubiana-Hulin, M Hacene, K

Citation: F. Spyratos et al., More about: Prognostic importance of low c-erbB2 expression in breast tumors - Response, J NAT CANC, 92(17), 2000, pp. 1443-1444

Authors: Ferrero-Pous, M Hacene, K Bouchet, C Le Doussal, V Tubiana-Hulin, M Spyratos, F

Citation: M. Ferrero-pous et al., Relationship between c-erbB-2 and other tumor characteristics in breast cancer prognosis, CLIN CANC R, 6(12), 2000, pp. 4745-4754

Authors: Ferrero-Pous, M Hacene, K Tubiana-Hulin, M Spyratos, F

Citation: M. Ferrero-pous et al., Prognostic importance of low c-erbB2 expression in breast tumors, J NAT CANC, 91(18), 1999, pp. 1584-1585

Authors: Chassevent, A Jourdan, ML Ferrero-Pous, M Colonna, M Romain, S Spyratos, F Roth, H Bolla, M

Citation: A. Chassevent et al., Standardization and quality control in the evaluation of proliferation parameters in T1T2, N0N1, M0 breast cancer: multicentric retrospective study II. DNA-ploidy and S-phase fraction, B CANCER, 86(7-8), 1999, pp. 685-691